Speaker: Jason Kihyuk Lee, MD, FRCPC, FAAAAI, FACAAI, Toronto Allergists, Toronto, ON
Moderator: Andréanne Côté, MD, FRCPC, Université Laval, Quebec City, QC
Type 2 inflammatory diseases are characterized by common shared immune dysregulation, which results in disease and organ specific signs and symptoms, impaired QoL and high burden of traditional standard-of-care treatments. It is commonly associated with an increased presence of other coexisting type 2 inflammatory diseases owing to the same dysregulation. This coexistence of comorbidities increases the patient’s overall disease burden, including impact on other type 2 driven dermatologic, respiratory and gastrointestinal diseases. Understanding the interrelationships will help the Respirologist optimize care for patients being treated.
At the end of this presentation, attendees will be able to:
- Review the pathophysiology of type 2 diseases and with common inflammatory pathways;
- Understand basic science and clinical evidence and how it is clinically relevant; and
- Integrate throughout cases that illustrate type 2 coexisting diseases.
CanMEDS Roles: Collaborator, Communicator, Health Advocate, Leader, Medical Expert, Professional, Scholar
This session is co-developed by the Canadian Thoracic Society and Sanofi and is planned to achieve scientific integrity, objectivity and balance.